Gynaecological Sarcoma C55
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Patients diagnosed with gynaecological sarcomas - Patients participating in REGSA - Written consent available and capable of giving consent - Language: sufficient knowledge of German or English - Willingness to participate in a 30-60 minute interview
Exclusion criteria
Exclusion criteria: - Lack of capacity to give consent - Medical reasons why participation would not be justifiable (e.g. advanced stage of disease with severe symptoms) - Withdrawal of consent - Excessive psychological stress - Lack of language skills, making participation in the study and understanding of information/interview questions impossible
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Due to the qualitative approach, endpoints and hypotheses are absent and exploratory research questions are used. Main research question: How do patients with gynaecological sarcomas experience the initial phase of diagnosis? Sub-research questions: - How do patients describe their experiences of distress? - How do those affected perceive the rarity of the disease and the associated uncertainties of those treating them? -How does the experience of patients differ depending on whether the primary treatment takes place in a certified centre or a non-certified centre? -How do the general conditions (e.g. process, environment) affect the experience during the initial diagnosis? The data is collected using a semi-structured qualitative interview guide. | — |
Secondary
| Measure | Time frame |
|---|---|
| Due to the qualitative approach, endpoints and hypotheses are absent and exploratory research questions are used. | — |
Countries
Germany
Contacts
Klinik für Gynäkologie mit Zentrum für Onkologische Chirurgie- Charité Universitätsmedizin Berlin